Oncusp Therapeutics
New York, US · Founded 2021 · 29 employees on LinkedIn · 6 known investors
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages. The company operates as a clinical-stage biopharmaceutical firm advancing multiple programs toward regulatory approval and patient access.
Founders & leadership
DB
Dr. Bing YuanCo-Founder, Chief Executive Officer
DE
Dr. Eric SlosbergCo-Founder, Chief Development Officer
DA
Dr. Andy FuCo-Founder, Chief Business Officer
BY
Bing Yuan, Ph.D., MBACo-Founder, Chief Executive Officer
ES
Eric Slosberg, Ph.D.Co-Founder, Chief Development Officer
AF
Andy Fu, PharmD, MBACo-Founder, Chief Business Officer
Investors · 6
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapOncosenx17 shared keywordsOncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.
Robinhood15 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with Oncusp Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Inforcer raises $50M to help prepare smaller businesses for a new world of AI and security riskstechcrunch.com · Jul 2026
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Oncusp Therapeutics do?
- OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages. The company operates as a clinical-stage biopharmaceutical firm advancing multiple programs toward regulatory approval and patient access.
- Who founded Oncusp Therapeutics?
- Oncusp Therapeutics was founded by Dr. Bing Yuan, Dr. Eric Slosberg, Dr. Andy Fu, Bing Yuan, Ph.D., MBA, Eric Slosberg, Ph.D., Andy Fu, PharmD, MBA in 2021.
- Who are Oncusp Therapeutics's investors?
- Oncusp Therapeutics's investors include OrbiMed, Catalio Capital Management, LP, F-Prime Capital, Sofinnova Ventures, Insight Partners, NVIDIA.
- Where is Oncusp Therapeutics headquartered?
- Oncusp Therapeutics is headquartered in New York, US.